Cargando…
Rescue of GM3 synthase deficiency by spatially controlled, rAAV-mediated ST3GAL5 delivery
GM3 synthase deficiency (GM3SD) is an infantile-onset epileptic encephalopathy syndrome caused by biallelic loss-of-function mutations in ST3GAL5. Loss of ST3GAL5 activity in humans results in systemic ganglioside deficiency and severe neurological impairment. No disease-modifying treatment is curre...
Autores principales: | Yang, Huiya, Brown, Robert H., Wang, Dan, Strauss, Kevin A., Gao, Guangping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10243808/ https://www.ncbi.nlm.nih.gov/pubmed/37014712 http://dx.doi.org/10.1172/jci.insight.168688 |
Ejemplares similares
-
Compound heterozygous variants within two conserved sialyltransferase motifs of
ST3GAL5
cause GM3 synthase deficiency
por: Rudy, Natasha, et al.
Publicado: (2022) -
rAAV-delivered PTEN therapeutics for prostate cancer
por: Ai, Jianzhong, et al.
Publicado: (2021) -
Extracorporeal Delivery of rAAV with Metabolic Exchange and Oxygenation
por: Bieber, Scott, et al.
Publicado: (2013) -
Durability of transgene expression after rAAV gene therapy
por: Muhuri, Manish, et al.
Publicado: (2022) -
PEG-mediated transduction of rAAV as a platform for spatially confined and efficient gene delivery
por: Zou, Liang, et al.
Publicado: (2022)